德源药业
(920735)
| 流通市值：29.01亿 | | | 总市值：32.80亿 |
| 流通股本：1.14亿 | | | 总股本：1.29亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 597,402,013.06 | 294,181,481.42 | 1,057,759,831.41 | 795,824,946.03 |
| 营业收入 | 597,402,013.06 | 294,181,481.42 | 1,057,759,831.41 | 795,824,946.03 |
| 二、营业总成本 | 439,712,417.99 | 229,701,547.23 | 800,394,506.98 | 606,640,908.29 |
| 营业成本 | 107,152,555.62 | 50,003,856.74 | 168,420,428.69 | 126,567,797.28 |
| 税金及附加 | 8,298,212.52 | 4,756,774.64 | 14,286,930.67 | 11,232,973.04 |
| 销售费用 | 221,331,494.17 | 127,411,874.12 | 441,591,769.6 | 340,355,068 |
| 管理费用 | 32,059,046.49 | 16,257,596.25 | 56,385,617.46 | 41,323,980.1 |
| 研发费用 | 71,002,646.06 | 31,354,908.28 | 120,273,721.58 | 87,557,375.76 |
| 财务费用 | -131,536.87 | -83,462.8 | -563,961.02 | -396,285.89 |
| 其中:利息费用 | 132,643.12 | 33,911.1 | 421,903.12 | 400,048.85 |
| 其中:利息收入 | 307,646.91 | 137,735.18 | 1,053,441.46 | 849,184.06 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 765,534.25 | 692,588.85 | 720,457.53 | 663,012.07 |
| 加:投资收益 | 3,981,779.37 | 1,926,317.53 | 8,269,307.96 | 6,288,256.42 |
| 资产处置收益 | -41,685.14 | - | -26,532.78 | - |
| 资产减值损失(新) | -1,485,009.12 | -1,373,497.63 | -4,023,580.81 | -2,891,728.65 |
| 信用减值损失(新) | -2,434,839.34 | -1,437,618.5 | -942,779.81 | -1,151,751.7 |
| 其他收益 | 3,130,809.74 | 1,758,638.52 | 6,882,391.61 | 3,848,732.38 |
| 四、营业利润 | 161,606,184.83 | 66,046,362.96 | 268,244,588.13 | 195,940,558.26 |
| 加:营业外收入 | 75,118.03 | 61,922.3 | 193,686.81 | 193,715.56 |
| 减:营业外支出 | 20,185.14 | 17,749.04 | 1,856,309.82 | 1,814,001.5 |
| 五、利润总额 | 161,661,117.72 | 66,090,536.22 | 266,581,965.12 | 194,320,272.32 |
| 减:所得税费用 | 33,001,893.77 | 10,577,033.82 | 29,652,889.54 | 35,393,901.38 |
| 六、净利润 | 128,659,223.95 | 55,513,502.4 | 236,929,075.58 | 158,926,370.94 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 128,659,223.95 | 55,513,502.4 | 236,929,075.58 | 158,926,370.94 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 128,659,223.95 | 55,513,502.4 | 236,929,075.58 | 158,926,370.94 |
| 扣除非经常损益后的净利润 | 124,031,452.67 | 52,991,376.92 | 228,590,944.52 | 154,379,025.36 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1 | 0.47 | 2.02 | 1.35 |
| (二)稀释每股收益 | 1 | 0.47 | 2.02 | 1.35 |
| 九、综合收益总额 | 128,659,223.95 | 55,513,502.4 | 236,929,075.58 | 158,926,370.94 |
| 归属于母公司股东的综合收益总额 | 128,659,223.95 | 55,513,502.4 | 236,929,075.58 | 158,926,370.94 |
| 公告日期 | 2026-08-25 | 2026-04-28 | 2026-03-05 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |